Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Woodwards Gripe Water - Alcohol Free & Sugar Free

Active Ingredient:
sodium hydrogen carbonate, terpeneless dill seed oil
Reckitt Benckiser Healthcare (UK) Ltd See contact details
About Medicine
{healthcare_pro_orange} This information is for use by healthcare professionals
Last updated on emc: 15 Nov 2023
1. Name of the medicinal product

Woodward's Gripe Water - Alcohol Free & Sugar Free

2. Qualitative and quantitative composition

Terpeneless Dill Seed Oil 2.3mg/5ml

Sodium Hydrogen Carbonate 52.5mg/5ml

Excipients with known effects:


15.73 mg (0.684mmol)/5ml

Propylene Glycol

200 mg /5ml


950 mg /5ml

Parahydroxybenzoates and their esters*

*nipasept sodium contains Sodium ethyl p-hydroxybenzoate (E215), Sodium propyl p-hydroxybenzoate (E217) and Sodium methyl p-hydroxybenzoate (E219).

For a full list of excipients see 6.1.

3. Pharmaceutical form

Oral solution

4. Clinical particulars
4.1 Therapeutic indications

For the symptomatic relief of distress associated with wind in infants up to one year old.

4.2 Posology and method of administration

For oral use

Adults & the Elderly: Not applicable


1 - 6 months old


One 5ml spoonful

6 - 12 months old


Two 5ml spoonsful

Under one month old


Not to be used

These doses may be given during or after each feed or up to six times in 24 hours.

4.3 Contraindications

Should not be used where impaired kidney function or hypersensitivity to hydroxybenzoates exists.

4.4 Special warnings and precautions for use

If symptoms persist, medical advice should be sought.

Keep all medicines out of the sight and reach of children.

Patients with rare hereditary problems of fructose intolerance should not take this medicine.

Label must include equivalent sentences of:

This medicine contains hydroxybenzoate derivatives (E215, E217 and E219) which may cause allergic reactions (possibly delayed).

This medicinal product contains 15.73 mg sodium per 5 ml, equivalent to 0.8% of the WHO recommended maximum daily intake of 2 g sodium for an adult.

This product is considered high in sodium. This should be particularly taken into account for those on a low salt diet.

This medicine contains 200 mg propylene glycol in each 5 ml which is equivalent to 200 mg/5 ml. If your child is less than 5 years old, talk to your doctor or pharmacist before giving them this medicine, in particular if they use other medicines that contain propylene glycol or alcohol.

If you suffer from a liver or kidney disease, do not take this medicine unless recommended by your doctor. Your doctor may carry out extra checks while you are taking this medicine.

This medicine contains maltitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine. May have a mild laxative effect. Calorific value 2.3 kcal/g maltitol.

Maximum Daily Dose:


188.76 mg (8.21 mmol)

Propylene glycol for child aged 6 - 12 months**:

2400 mg

Propylene glycol for child aged 1 - 6 months***:

1200 mg

Maltitol liquid:

11.4 g

**(343 mg/kg/day based on weight of 7 kg for a 6 month old)

*** (300 mg/kg/day based on weight of 4 kg for a 1 month old)

This medicine contains parahydroxybenzoates and their esters* which may cause allergic reactions (possibly delayed).

4.5 Interaction with other medicinal products and other forms of interaction

A time-interval of 2 hours should be considered between intake of this product and the administration of other medicinal products.

4.6 Fertility, pregnancy and lactation

Not applicable

4.7 Effects on ability to drive and use machines

Not applicable

4.8 Undesirable effects

Adverse events which have been associated with dill seed oil and sodium bicarbonate are given below, tabulated by system organ class and frequency.

Frequencies are defined as: Very common (≥ 1/10); Common (≥ 1/100 and <1/10); Uncommon (≥ 1/1000 and <1/100); Rare (≥ 1/10,000 and <1/1000);

Very rare (< 1/10,000); Not known (cannot be estimated from the available data). Within each frequency grouping, adverse events are presented in order of decreasing seriousness.

System Organ Class


Adverse Events

Immune System Disorders

Not known


Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at:

4.9 Overdose

Symptoms following overdose are rare and are generally due to the effects of sodium hydrogen carbonate. These may include diarrhoea, metabolic alkalosis and hypernatraemia. In the event of severe overdosing, medical advice should be sought immediately.

Symptoms of hypernatraemia may include drowsiness and irritability, pyrexia and tachypnoea. In more severe instances of acute sodium overload, signs of dehydration and convulsions may occur.

The treatment of hypernatraemia includes repair of any dehydration present and gradual reduction of the plasma sodium. The alkalosis, if present, will respond usually to the treatment of hypernatraemia. At all times intensive monitoring of the electrolytes, and patients circulatory and central nervous system are necessary.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Sodium Hydrogen Carbonate has a well-established antacid action. Dill Seed Oil is a widely used aromatic carminative especially for use in the treatment of flatulence in children.

5.2 Pharmacokinetic properties

Not applicable

5.3 Preclinical safety data

Not applicable

6. Pharmaceutical particulars
6.1 List of excipients


Propylene glycol

Maltitol Liquid

Nipasept (Sodium Methyl Parahydroxybenzoate, Sodium Ethyl Parahydroxybenzoate, Sodium Propyl Parahydroxybenzoate)

Disodium Edetate

Purified water

6.2 Incompatibilities

None known

6.3 Shelf life

18 months unopened

14 days after opening

6.4 Special precautions for storage

Do not store above 25° C

6.5 Nature and contents of container

Clear, soda-lime-silica Type III pharmaceutical grade glass bottle with an expanded polyethylene wadded cap containing 150ml of product.

6.6 Special precautions for disposal and other handling


7. Marketing authorisation holder

Reckitt Benckiser Healthcare (UK) limited

103-105 Bath Road




United Kingdom

8. Marketing authorisation number(s)

PL 00063/0698

9. Date of first authorisation/renewal of the authorisation


10. Date of revision of the text


Reckitt Benckiser Healthcare (UK) Ltd
Company image
RB Consumer Relations, PO Box 4644, SLOUGH, SL1 0NS, UK
0333 2005 345
Medical Information Direct Line
0333 2005 345
Customer Care direct line
0333 2005 345